Literature DB >> 282649

Localization of cholecystokinin-like immunoreactivity in isolated nerve terminals.

M Pinget, E Straus, R S Yalow.   

Abstract

Subcellular fractionation of the rat cerebral cortex demonstrated the presence of immunoreactive cholecystokinin in the pellet identified by electron microscopy as containing a high proportion of synaptic vesicles. The recovery in this pellet of 40% of the total immunoreactivity in the initial cortical extract is quite comparable to the recovery of other peptides such as vasoactive intestinal polypeptide and somatostatin, which are also located in synaptosomes and for which roles as neuroregulators or transmitters have been suggested. The evidence of concentration of cholecystokinin-like peptides in the synaptosomal pellet is consistent with our earlier demonstration by immunohistochemical techniques of cholecystokinin's presence in rabbit cerebral cortical neurons. These observations and the evidence for diminished concentration of cholecystokinin-like peptides in the brains of hyperphagic mice are consistent with cholecystolinin's suggested role as a neuroregulator for appetite.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282649      PMCID: PMC393174          DOI: 10.1073/pnas.75.12.6324

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Intraperitoneal and intracranial cholecystokinin depress operant responding for food.

Authors:  S Maddison
Journal:  Physiol Behav       Date:  1977-12

3.  Immunohistochemical localization in rabbit brain of a peptide resembling the COOH-terminal octapeptide of cholecystokinin.

Authors:  E Straus; J E Muller; H S Choi; F Paronetto; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

4.  Species specificity of cholecystokinin in gut and brain of several mammalian species.

Authors:  E Straus; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

6.  Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog.

Authors:  J F Rehfeld
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

7.  Immunoreactive component resembling cholecystokinin octapeptide in intestine.

Authors:  G J Dockray
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

8.  Multiple immunoreactive forms of vasoactive intestinal peptide in human colonic mucosa.

Authors:  R Dimaline; G J Dockray
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

9.  Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.

Authors:  A Giachetti; S I Said; R C Reynolds; F C Koniges
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Cholecystokinin and its COOH-terminal octapeptide in the pig brain.

Authors:  J E Muller; E Straus; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  9 in total

1.  Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies.

Authors:  C A Tamminga; R L Littman; L D Alphs; T N Chase; G K Thaker; A M Wagman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens.

Authors:  P Paudice; M Raiteri
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

3.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

4.  Few cortical cholecystokinin immunoreactive neurons have long projections.

Authors:  K B Seroogy; J H Fallon; S E Loughlin; F M Leslie
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

5.  Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoctapeptides.

Authors:  J Eng; Y Shiina; Y C Pan; R Blacher; M Chang; S Stein; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.

Authors:  T Griesbacher; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

7.  Brain cholecystokinin and nutritional status in rats and mice.

Authors:  B S Schneider; J W Monahan; J Hirsch
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

8.  Modulation of cholecystokinin concentrations in the rat hippocampus by chelation of heavy metals.

Authors:  K Stengaard-Pedersen; L I Larsson; K Fredens; J F Rehfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition.

Authors:  Alexis Harold; Yutaka Amako; Junichi Hachisuka; Yulong Bai; Meng Yen Li; Linda Kubat; Jan Gravemeyer; Jonathan Franks; Julia R Gibbs; Hyun Jung Park; Elena Ezhkova; Jürgen C Becker; Masahiro Shuda
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.